Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Harri Hakala"'
Autor:
Ian Weeks, Stuart J. Moat, Petra Furu, Hanna Polari, Teemu Korpimaki, Pauliina Mäkinen, Liisa Meriö, Harri Hakala
Publikováno v:
Clinical Chemistry. 63:908-914
BACKGROUNDDuchenne muscular dystrophy (DMD) is a progressive, lethal X-linked neuromuscular disorder with an average worldwide incidence of 1:5000. Blood spot creatine kinase (CK) enzyme assays previously used in newborn screening programs for DMD ar
Publikováno v:
Building Services Engineering Research and Technology. 38:421-435
This article presents a study of the potential energy efficiency improvement by means of adjusting the lift counterweight. The lift energy consumption in different counterweight set-ups is studied by employing measured lift traffic and energy consump
Autor:
Semen Uimonen, Toni Tukia, Claudio Donghi, Hannu Nousu, Xiao Liang Cai, Dirk Lange, Matti Lehtonen, Harri Hakala, Marja-Liisa Siikonen
Publikováno v:
Energy and Buildings. 125:287-297
Lack of information on energy consumption patterns of intermittent-operating escalators and unawareness of building owners of potential energy savings constitute the main obstacles for the penetration of energy-efficient escalator technology. Even th
Publikováno v:
Letters in Organic Chemistry. 6:659-663
Synthesis of a building block based on 6,6’-(1H-pyrazole-1,3-diyl)bis(pyridine) (3) that allows introduction of photoluminescent lanthanide(III) chelates to the synthetic oligopeptides on solid phase using the standard Fmoc chemistry is described.
Publikováno v:
Bioconjugate Chemistry. 19:1269-1273
Four acyclic nucleoside triphosphates (derivatives of cytosine, thymine, 7-deazaadenine, and 7-deazaguanine) labeled with nonluminescent europium, terbium, dysprosium, and samarium chelates of 2,2',2'',2'''-[[4-(4-isothiocyanatophenyl)ethyl]pyridine-
Publikováno v:
Helvetica Chimica Acta. 90:607-615
The copper(I)-catalyzed dipolar [2+3] cycloaddition reaction of an azide and a terminal alkyne is exploited in the preparation of various europium(III), terbium(III), and dysprosium(III) chelates (Schemes 1–3). By changing the nature of the alkyne
Autor:
Harri Hakala, Pertti Hurskainen, Veli-Matti Mukkala, Lassi Jaakkola, Jari Peuralahti, Jari Hovinen
Publikováno v:
Journal of Peptide Science. 12:199-205
Synthesis of a building block that allows introduction of photoluminescent europium(III) and samarium(III) chelates to synthetic oligopeptides on solid phase using standard Fmoc chemistry is described. Upon completion of the oligopeptide synthesis, t
Autor:
Jari Peuralahti, Päivi Liitti, Veli-Matti Mukkala, Jarkko Karvinen, Jari Hovinen, Harri Hakala
Publikováno v:
Journal of Luminescence. 113:17-26
Seventeen novel samarium (Sm)(III) chelates containing two iminodiacetic acid moieties were synthesised and their luminescence properties were measured with the aim of developing new labels for biochemical applications. The chelates contained differe
Autor:
Jari Peuralahti, Harri Hakala, and Alice Ylikoski, Pekka Tallqvist, Veli-Matti Mukkala, Lassi Jaakkola, Jenni Kunttu, Jari Hovinen
Publikováno v:
Bioconjugate Chemistry. 16:700-709
The synthesis of phosphoramidite building blocks that allow introduction of luminescent europium(III), terbium(III), dysprosium(III), and samarium(III) chelates to oligonucleotides on the solid phase is described. Several labeled oligonucleotides usi
Autor:
Jari Hovinen, Pia Ollikka, Veli-Matti Mukkala, Annika Elomaa, Harri Hakala, Alice Ylikoski, Ilkka Hemmilä
Publikováno v:
Clinical Chemistry. 50:1943-1947
Laboratories performing genetic screening studies need simplified methods that allow automation for nucleic acid analysis. Ideally, a method should have as few handling steps as possible and allow the use of a closed-tube assay format to reduce the r